作者: M Ryan , CC Campisi , CS Campisi , P DiSumma , C Campisi
DOI:
关键词: Anesthesia 、 Surgery 、 Lymphedema 、 Cellulite 、 Medicine 、 Peripheral 、 Combined treatment 、 Perfusion
摘要: Intermittent negative pressure deviceswere initially developed by NASA to enhanceblood perfusion and combat a reduction inorthostatic tolerance. Investigational studieshave demonstrated that the differentialproduces changes in blood cardiacsystems also documented inweight cellulite obese patients. Althoughthe mechanisms are not known, previousinvestigation has reported inlymphedematous limbs. These initial resultssuggested us inclusion of intermittentnegative into lymphedematreatment protocol would be beneficial. Wesubsequently undertook study 50 patientswith lymphedema adding intermittent negativepressure our CLyFT comparedthem withoutintermittent pressure. We found asignificant difference between groups withan additional 7% lymphedemavolume (p=0.008). Our results indicatethat therapy protocolwas beneficial further incorporation intoother protocols should investigated.